1. Home/
  2. Compounds/
  3. doxorubicin:navitoclax (2:1 mol/mol)

doxorubicin:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2doxorubicin:navitoclax (2:1 mol/mol)
PharmacoGx doxorubicin:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to doxorubicin:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA CHKB-CPT1B CTRPv2 pan-cancer AAC 0.17 2e-06
mRNA LAT2 CTRPv2 pan-cancer AAC 0.18 2e-06
mRNA LUC7L CTRPv2 pan-cancer AAC 0.17 2e-06
mRNA LATS1 CTRPv2 pan-cancer AAC 0.15 2e-06
mRNA SYS1 CTRPv2 pan-cancer AAC -0.16 2e-06
mRNA CHD3 CTRPv2 pan-cancer AAC 0.16 2e-06
mRNA RP11-15H20.8 CTRPv2 pan-cancer AAC 0.16 2e-06
mRNA KCNA6 CTRPv2 pan-cancer AAC 0.16 2e-06
mRNA NONO CTRPv2 pan-cancer AAC 0.16 2e-06
mRNA ZMYM2 CTRPv2 pan-cancer AAC 0.16 2e-06
Download CSV